Updated Jul 16, 2026 · Last SEC filing 2026-06-04
BIOMARIN PHARMACEUTICAL INC (BMRN) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-04. 5 Form 8-K material event filings were reported by BMRN in the last 90 days. 1 Form 144 notices of proposed sale were filed for BMRN stock. InsiderAlpha tracks every BMRN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001048477 |
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-06-04 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| HOMBACH ROBERT J. | Director | A — Grant or award | 7.5K | $0.00 | — | SEC | |
| Bodem Barbara W. | Director | A — Grant or award | 7.5K | $0.00 | — | SEC | |
| ANDERSON ELIZABETH M | Director | A — Grant or award | 7.5K | $0.00 | — | SEC | |
| Enyedy Mark J | Director | A — Grant or award | 7.5K | $0.00 | — | SEC | |
| Countouriotis Athena | Director | A — Grant or award | 7.5K | $0.00 | — | SEC | |
| Walbert Timothy P | Director | A — Grant or award | 7.5K | $0.00 | — | SEC | |
| Ho Maykin | Director | A — Grant or award | 7.5K | $0.00 | — | SEC | |
| CLARK IAN T | Director | A — Grant or award | 7.5K | $0.00 | — | SEC | |
| Dere Willard H | Director | A — Grant or award | 7.5K | $0.00 | — | SEC | |
| Hubbard Cristin | EVP, Chief Commercial Officer | F — Tax withholding / forfeiture | 2.3K | $50.20 | $116K | SEC | |
| Friberg Gregory R | EVP, Chief R&D Officer | S — Open-market sale | 3.3K | $53.85 | $177K | SEC | |
| Davis George Eric | EVP, Chief Legal Officer | F — Tax withholding / forfeiture | 1.3K | $56.05 | $71K | SEC | |
| Hubbard Cristin | EVP, Chief Commercial Officer | F — Tax withholding / forfeiture | 1.2K | $56.05 | $70K | SEC | |
| Mueller Brian | EVP, Chief Financial Officer | F — Tax withholding / forfeiture | 2.1K | $56.05 | $119K | SEC | |
| Guyer Charles Greg | EVP, Chief Technical Officer | F — Tax withholding / forfeiture | 1.7K | $56.05 | $95K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for BIOMARIN PHARMACEUTICAL INC (BMRN). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| CLARK IAN T | 1 | — |
| Bodem Barbara W. | 1 | — |
| Hubbard Cristin | 1 | $116K |
| ANDERSON ELIZABETH M | 1 | — |
| Friberg Gregory R | 1 | $177K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BMRN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live BMRN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.